Inflatherm Kit
NDC Package 72835-701-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Inflatherm (diclofenac sodium and menthol / camphor gel) kits is carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. This formulation utilizes a kit delivery system. Marketed by V2 Pharma, Llc, this product is identified by NDC 72835-701.

Identification & Billing

NDC Package Code
72835-701-02
Package Description
1 KIT in 1 CARTON * 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0228-2551-06) * 85 g in 1 BOTTLE, PLASTIC (61577-3234-5)
Product Code
72835-701
11-Digit Billing Format
72835070102
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Inflatherm
Non-Proprietary Name
Diclofenac Sodium And Menthol / Camphor Gel
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation).Diclofenac sodium delayed-release tablets, USP are indicated:For relief of the signs and symptoms of osteoarthritisFor relief of the signs and symptoms of rheumatoid arthritisFor acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis

Regulatory & Marketing

Labeler Name
V2 Pharma, Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
08-13-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72835-701-02 identifies a specific commercial package of 1 kit in 1 carton * 60 tablet, delayed release in 1 bottle (0228-2551-06) * 85 g in 1 bottle, plastic (61577-3234-5) of Inflatherm, a human prescription drug labeled by V2 Pharma, Llc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by V2 Pharma, Llc on August 13, 2024. The current certification is valid through December 31, 2026.

How is this V2 Pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72835070102. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72835-701-02
11-Digit CMS (5-4-2)
72835-0701-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.